
|Videos|July 24, 2021
Pipeline: Presbyopia, night vision disturbance up next for Vyluma
Advertisement
Presbyopia and night vision disturbance will follow myopia as a clinical focus for Vyluma. Navneet Puri, PhD, the company’s founder, chairman, and CEO, shares what is next.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Simplifying the treatment of ocular surface disease
2
Classifying dry eye by root cause: A step toward precision medicine
3
3D-printed contact lenses offer patient-specific fit in 20 minutes
4
Atropine, aspherical lenses enter trial for childhood myopia
5






















